Elevated levels of activated mTOR (phosphorylated mTOR) are commonly found in CRC tissues, which correlate with advanced tumor stages characterized by the inhibition of apoptosis, heightened tumor aggressiveness, and diminished patient survival [75–77]. This evidence concerns the gene MTOR and neoplasm.